EBITDA: Income before interest, taxes, depreciation and amortization.
Response Genetics Inc. (RGDXQ) had EBITDA of $-3.42M for the most recently reported fiscal quarter, ending 2015-03-31.
| Income Statement Financials | |
$3.79M |
|
$-4.02M |
|
$2.31M |
|
$1.48M |
|
$7.43M |
|
$-3.64M |
|
$-0.38M |
|
$-4.02M |
|
$-4.02M |
|
$-4.02M |
|
$-4.02M |
|
$-4.02M |
|
$-4.02M |
|
$-3.64M |
|
|
EBITDA |
$-3.42M |
38.80M |
|
38.80M |
|
$-0.10 |
|
$-0.10 |
|
| Balance Sheet Financials | |
$8.76M |
|
$1.27M |
|
$2.02M |
|
$10.78M |
|
$4.88M |
|
$10.84M |
|
$10.84M |
|
$15.72M |
|
$-4.94M |
|
$-5.52M |
|
$-4.94M |
|
38.80M |
|
| Cash Flow Statement Financials | |
$-1.88M |
|
$-0.00M |
|
$1.42M |
|
$2.22M |
|
$1.73M |
|
$-0.49M |
|
$0.11M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.80 |
|
-- |
|
-- |
|
1.84 |
|
-2.22 |
|
38.94% |
|
-96.05% |
|
-96.05% |
|
-- |
|
-106.01% |
|
-106.01% |
|
$-1.88M |
|
-- |
|
-- |
|
-- |
|
0.35 |
|
-- |
|
0.63 |
|
143.86 |
|
81.39% |
|
72.80% |
|
-37.28% |
|
-68.10% |
|
$-0.13 |
|
$-0.05 |
|
$-0.05 |
|